Literature DB >> 21928003

Usefulness of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance cholangiography for detecting mucin retention in bile ducts: a rare intraductal papillary mucinous neoplasm of the bile duct.

Hodaka Oki1, Yoshiko Hayashida, Tomohiro Namimoto, Takatoshi Aoki, Yukunori Korogi, Yasuyuki Yamashita.   

Abstract

We report a 75-year-old man with radiological evidence of a 4.5 × 3.0 cm cystic mass and polypoid masses in the left hepatic lobe. Study of surgical specimens returned a definitive diagnosis of intraductal papillary mucinous neoplasm of the bile duct (IPMN-B). IPMN-B, thought to be the counterpart of intraductal papillary mucinous neoplasm of the pancreas (IPMN), is frequently associated with marked mucin production. We describe a rare case of IPMN-B in which gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance cholangiography was useful for detecting mucin retention in the bile ducts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21928003     DOI: 10.1007/s11604-011-0593-7

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  10 in total

1.  Contrast-enhanced magnetic resonance cholangiography using mangafodipir compared with standard T2W MRC sequences: a pictorial essay.

Authors:  Declan Sheppard; Lynsay Allan; Pat Martin; Trudy McLeay; Wendy Milne; J Graeme Houston
Journal:  J Magn Reson Imaging       Date:  2004-08       Impact factor: 4.813

2.  Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions.

Authors:  Ta-Sen Yeh; Jeng-Hwei Tseng; Tse-Ching Chen; Nai-Jen Liu; Cheng-Tang Chiu; Yi-Yin Jan; Miin-Fu Chen
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

3.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.

Authors:  Yasuni Nakanuma; Yasunori Sato; Kenichi Harada; Motoko Sasaki; Jing Xu; Hiroko Ikeda
Journal:  World J Hepatol       Date:  2010-12-27

4.  Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts.

Authors:  Ta-Sen Yeh; Jeng-Hwei Tseng; Cheng-Tang Chiu; Nai-Jen Liu; Tse-Ching Chen; Yi-Yin Jan; Miin-Fu Chen
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

5.  Gadobenate dimeglumine-enhanced MRI of intraductal papillary mucinous tumor of the bile ducts.

Authors:  Mi-Suk Park; Jeong-Sik Yu; Dong Ki Lee; Dong-Sup Yoon; Seung-Whan Cha; Ki Whang Kim
Journal:  J Magn Reson Imaging       Date:  2007-03       Impact factor: 4.813

6.  Biliary MR imaging with Gd-EOB-DTPA and its clinical applications.

Authors:  Nam Kyung Lee; Suk Kim; Jun Woo Lee; Suk Hong Lee; Dae Hwan Kang; Gwang Ha Kim; Hyung Il Seo
Journal:  Radiographics       Date:  2009-10       Impact factor: 5.333

Review 7.  Intraductal papillary mucinous tumor of the bile ducts.

Authors:  Jae Hoon Lim; Kwon-Ha Yoon; Seong Hyun Kim; Ha Young Kim; Hyo Keun Lim; Sang Yong Song; Kyung Jin Nam
Journal:  Radiographics       Date:  2004 Jan-Feb       Impact factor: 5.333

8.  Clinicopathological features of "intraductal papillary neoplasm of the bile duct" and patient outcome after surgical resection.

Authors:  Atsushi Nanashima; Naoe Kinoshita; Yasuni Nakanuma; Yoh Zen; Yorihisa Sumida; Takafumi Abo; Shigekazu Hidaka; Hiroaki Takeshita; Toru Yasutake; Tomayoshi Hayashi; Takeshi Nagayasu
Journal:  Hepatogastroenterology       Date:  2008 Jul-Aug

9.  Biliary intraductal papillary-mucinous neoplasm manifesting only as dilatation of the hepatic lobar or segmental bile ducts: imaging features in six patients.

Authors:  Jae Hoon Lim; Kee-Taek Jang; Dongil Choi
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

Review 10.  Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.

Authors:  Peter Reimer; Günter Schneider; Wolfgang Schima
Journal:  Eur Radiol       Date:  2004-02-25       Impact factor: 5.315

  10 in total
  5 in total

1.  Gd-EOB-DTPA-enhanced magnetic resonance imaging for bile duct intraductal papillary mucinous neoplasms.

Authors:  Shi-Hong Ying; Xiao-Dong Teng; Zhao-Ming Wang; Qi-Dong Wang; Yi-Lei Zhao; Feng Chen; Wen-Bo Xiao
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

2.  Clinicopathological findings and imaging features of intraductal papillary neoplasms in bile ducts.

Authors:  Honghui Zhang; Zhendong Zhong; Gaoyin Kong; Junaid Khan; Lianhong Zou; Yu Jiang; Xiehong Liu; Yixun Tang; Bo Jiang; Chuang Peng; Yinghui Song; Sulai Liu
Journal:  PeerJ       Date:  2020-09-30       Impact factor: 2.984

Review 3.  Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current status.

Authors:  Reiji Sugita
Journal:  World J Hepatol       Date:  2013-12-27

Review 4.  Intraductal papillary neoplasm of the bile ducts: A case report and literature review.

Authors:  Yaohong Tan; Clara Milikowski; Yanelba Toribio; Adam Singer; Claudia P Rojas; Monica T Garcia-Buitrago
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

Review 5.  Cystic tumor of the liver without ovarian-like stroma or bile duct communication: two case reports and a review of the literature.

Authors:  Norihiro Kishida; Masahiro Shinoda; Yohei Masugi; Osamu Itano; Yoko Fujii-Nishimura; Akihisa Ueno; Minoru Kitago; Taizo Hibi; Yuta Abe; Hiroshi Yagi; Akihiro Tanimoto; Minoru Tanabe; Michiie Sakamaoto; Yuko Kitagawa
Journal:  World J Surg Oncol       Date:  2014-07-21       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.